載入...
β-Adrenergic Receptor-Mediated Cardiac Contractility is Inhibited via Vasopressin Type 1A-Receptor-Dependent Signaling
BACKGROUND: Enhanced arginine vasopressin (AVP) levels are associated with increased mortality during end-stage human heart failure (HF), and cardiac AVP type 1A receptor (V1AR) expression becomes increased. Additionally, mice with cardiac-restricted V1AR overexpression develop cardiomyopathy and de...
Na minha lista:
發表在: | Circulation |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , |
格式: | Artigo |
語言: | Inglês |
出版: |
2014
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4229385/ https://ncbi.nlm.nih.gov/pubmed/25205804 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCULATIONAHA.114.010434 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|